[2026-03-26]South Korea Launches Full-Cycle Support for Pharma-Bio Ventures to Foster Blockbuster Drug Firms
South Korea is establishing a full-cycle support system for pharmaceutical and biotech ventures.
The policy aims to nurture companies capable of creating blockbuster drugs and accelerate global market entry.
Announced on March 24, 2026, the initiative is now being implemented by key government agencies.